Stockreport

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]

TScan Therapeutics, Inc.  (TCRX) 
PDF This compares to loss of $0.78 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 30%. [Read more]